Publications by authors named "Ray Manneh"

Claim this Profile
G
Guiding first-line treatment decisions in advanced urothelial carcinoma: a global survey.
Enrique Grande, Joaquim Bellmunt, Syed A Hussain, Mubarak M Al Mansour, Aristotle Bamias, Ray Manneh

Oncologist· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP Inhibitors for Metastatic CRPC: More Answers than Questions, a Systematic Review and Meta-Analysis.
Ray Manneh, Javier Molina-Cerrillo, Guillermo de Velasco, Linda Ibatá, Susan Martínez

Pharmaceuticals (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triplet systemic therapy for hormone-sensitive prostate cancer: a critical review with a multidisciplinary approach.
Almudena Zapatero, Teresa Alonso-Gordoa, Alfredo Rodríguez Antolín, Felipe Couñago, Noelia Sanmamed, Ray Manneh

Oncol Rev· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer: The Randomized, Double-Blind, Phase III KEYNOTE-921 Trial.
Daniel P Petrylak, Raffaele Ratta, Nobuaki Matsubara, Ernesto Korbenfeld, Rustem Gafanov, Ray Manneh

J Clin Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apalutamide in Metastatic Castration-sensitive Prostate Cancer: Results from the Multicenter Real-world ARON-3 Study.
Matteo Santoni, Thomas Büttner, Pasquale Rescigno, Ondrej Fiala, Nicolò Cavasin, Ray Kopp Manneh

Eur Urol Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations.
Lorena Incorvaia, Fernando Sabino Marques Monteiro, Francesco Massari, Se Hoon Park, Giandomenico Roviello, Ray Manneh

Cancer Immunol Immunother· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline mutations of breast cancer susceptibility genes through expanded genetic analysis in unselected Colombian patients.
Diana Carolina Sierra-Díaz, Adrien Morel, Dora Janeth Fonseca-Mendoza, Nora Contreras Bravo, Nicolas Molano-Gonzalez, Ray Manneh

Hum Genomics· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert consensus: Profiling and management of advanced or metastatic epithelial ovarian cancer.
Marc E Pierre, Ray Manneh, Abraham Hernández, Juliana Rodríguez, Angélica V Fletcher

Rev Colomb Obstet Ginecol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Study of Homologous Recombination Repair Gene Mutation Prevalence in Patients With Advanced Prostate Cancer From Latin America: Challenges and Future Approaches.
Ray Manneh, Carmen Alaez Verson, Angel Martin, Arturo Delgado, Pedro H Isaacsson Velho

JCO Precis Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Metastatic Urothelial Carcinoma in Emerging Markets (EM): An Expert Opinion.
Andrey Soares, Maria T Bourlon, Alvin Wong, Amit Joshi, Denis Jardim, Ray Manneh

Clin Genitourin Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study.
Ondřej Fiala, Sebastiano Buti, Hideki Takeshita, Yohei Okada, Francesco Massari, Ray Manneh

Cancer Immunol Immunother· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of vaccination against COVID-19 on patients with cancer in ACHOC-C19 study: Real world evidence from one Latin American country.
Aylen Vanessa Ospina, Ricardo Brugés, Iván Triana, Guillermo Sánchez-Vanegas, Angela Barrero, Ray Manneh

J Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world evidence of nivolumab for non-small-cell lung cancer in a developing country.
Mauricio Luján, Mauricio Lema, Beatriz Preciado, Camila Lema, Jorge Egurrola, Raimundo Manneh, Ray Manneh

J Investig Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frontline immune checkpoint inhibitor-based combination therapy in metastatic renal cell carcinoma patients with poor performance status.
Lucía Carril-Ajuria, Emeline Colomba, Carmen Romero-Ferreiro, Luigi Cerbone, Raffaele Ratta, Ray Manneh

Eur J Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Dose Somatostatin Analogs for the Treatment of Neuroendocrine Neoplasms: where are we Now?
Teresa Alonso-Gordoa, Ray Manneh, Enrique Grande, Javier Molina-Cerrillo

Curr Treat Options Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Inhibitor Combination Therapy versus Sunitinib as First-Line Treatment for Favorable-IMDC-Risk Advanced Renal Cell Carcinoma Patients: A Meta-Analysis of Randomized Clinical Trials.
Ray Manneh, Mauricio Lema, Lucía Carril-Ajuria, Linda Ibatá, Susan Martínez

Biomedicines· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete response and renal cell carcinoma in the immunotherapy era: The paradox of good news.
Francisco Zambrana, Lucia Carril-Ajuria, Alfonso Gómez de Liaño, Nieves Martinez Chanza, Ray Manneh

Cancer Treat Rev· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor Cells as a Biomarker of Survival and Response to Radium-223 Therapy: Experience in a Cohort of Patients With Metastatic Castration-Resistant Prostate Cancer.
Joan Carles, Daniel Castellano, María-José Méndez-Vidal, Begoña Mellado, María-Isabel Saez, Ray Manneh

Clin Genitourin Cancer· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urothelial cancer proteomics provides both prognostic and functional information.
Guillermo de Velasco, Lucia Trilla-Fuertes, Angelo Gamez-Pozo, Maria Urbanowicz, Gustavo Ruiz-Ares, Ray Manneh

Sci Rep· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Significance of Venous Thromboembolic Events in Disseminated Germ Cell Cancer Patients.
Enrique Gonzalez-Billalabeitia, Daniel Castellano, Nora Sobrevilla, Josep Guma, David Hervas, Ray Manneh

J Natl Cancer Inst· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Well-Differentiated Grade 2, Type 3 Gastrointestinal Neuroendocrine Tumour with Bilateral Metastatic Ovarian Involvement: Report of an Unusual Case.
Ray Manneh, Daniel Castellano, Oscar Caso, Carmelo Loinaz, Jesús Jiménez

Case Rep Oncol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis